Rubicon Research Ltd (RUBI)

Currency in INR
788.60
+14.60(+1.89%)
Closed·
Earnings results expected today
RUBI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
766.10794.55
52 wk Range
485.00822.00
Key Statistics
Bid/Ask
781.60 / 788.60
Prev. Close
788.6
Open
772.7
Day's Range
766.1-794.55
52 wk Range
485-822
Volume
91.32K
Average Volume (3m)
203.31K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RUBI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
857.50
Upside
+8.74%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Rubicon Research Ltd Company Profile

Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. Its primary proprietary technologies for drug delivery comprising RubiSRL for the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies; and RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption. The company develops products in the areas of analgesics/pain management, hypokalemia, gastrointestinal, cardiovascular, skeletal muscle relaxants, metabolic, central nervous system, nicotine replacement therapy, and immunosuppressant. The company was incorporated in 1999 and is based in Mumbai, India.

Employees
903
Market
India

Compare RUBI to Peers and Sector

Metrics to compare
RUBI
Peers
Sector
Relationship
P/E Ratio
62.8x27.6x−0.6x
PEG Ratio
-0.280.00
Price/Book
20.0x3.7x2.6x
Price / LTM Sales
8.1x3.7x3.3x
Upside (Analyst Target)
9.0%8.5%45.1%
Fair Value Upside
Unlock2.6%5.5%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 857.50
(+8.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Dec 03, 2025
EPS / Forecast
3.30 / --
Revenue / Forecast
4.12B / --
EPS Revisions
Last 90 days

RUBI Income Statement

People Also Watch

589.40
TENN
+4.21%
706.30
ATHR
+1.07%
378.70
JAIE
+2.61%
505.45
LENS
+4.32%
181.25
EPAK
+0.32%

FAQ

What Is the Rubicon Research (RUBI) Stock Price Today?

The Rubicon Research stock price today is 788.60 INR.

What Stock Exchange Does Rubicon Research Trade On?

Rubicon Research is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Rubicon Research?

The stock symbol for Rubicon Research is "RUBI."

What Is the Rubicon Research Market Cap?

As of today, Rubicon Research market cap is 129.92B INR.

What Is Rubicon Research's Earnings Per Share (TTM)?

The Rubicon Research EPS (TTM) is 13.03.

When Is the Next Rubicon Research Earnings Date?

Rubicon Research will release its next earnings report on Feb 25, 2026.

From a Technical Analysis Perspective, Is RUBI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Rubicon Research Stock Split?

Rubicon Research has split 0 times.

How Many Employees Does Rubicon Research Have?

Rubicon Research has 903 employees.

What is the current trading status of Rubicon Research (RUBI)?

As of Feb 25, 2026, Rubicon Research (RUBI) is trading at a price of 788.60 INR, with a previous close of 788.60 INR. The stock has fluctuated within a day range of 766.10 INR to 794.55 INR, while its 52-week range spans from 485.00 INR to 822.00 INR.

What Is Rubicon Research (RUBI) Price Target According to Analysts?

The average 12-month price target for Rubicon Research is 857.50 INR, with a high estimate of 865 INR and a low estimate of 850 INR. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +8.74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.